The transcription factor Ebf1 is an important determinant of early B lymphopoiesis. To gain insight into the functions of Ebf1 at distinct stages of differentiation, we conditionally inactivated Ebf1. We found that Ebf1 is 
B lymphopoiesis is a complex process of differentiation that converts lineage-committed progenitors into highly specialized antibody-secreting plasma cells. In the bone marrow, differentiation of lymphoid progenitor cells into pro-B cells involves the rearrangement of the immunoglobulin heavy chain (IgH) locus and proliferation in response to interleukin-7 (IL-7) (Dias et al. 2005; Nutt and Kee 2007; Malin et al. 2010) . Successful IgH gene rearrangement generates pre-B cells that express the pre-B-cell receptor (pre-BCR) and undergo rearrangement of the Ig light chain loci to further differentiate into immature B cells. These cells egress into the peripheral lymphoid organs and are competent to respond to antigenic stimulation via the BCR. Survival of circulating mature B cells is dependent on tonic BCR signals via the PI3 kinase (PI3K)/Akt pathway and on B-cell-activating factor receptor (BAFF-R) signals (Kraus et al. 2004; Mecklenbrauker et al. 2004; Srinivasan et al. 2009 ). Antigenic stimulation of B cells results in the formation of germinal center (GC) B cells that undergo extensive proliferation, somatic hypermutation of Ig genes, and IgH class switch recombination (Klein and Dalla-Favera 2008) .
Early specification of the B-cell lineage program and loss of alternate lineage potential are regulated by a network of transcription factors, including E2A, Ebf1, and Pax5 (for review, see Nutt and Kee 2007; Mandel and Grosschedl 2010) . Loss-of-function analyses of Ebf1 and E2a (Tcf3) in mice indicated that both transcription factors are necessary for the generation of pro-B cells that undergo rearrangement of the IgH gene locus (Bain et al. 1994; Zhuang et al. 1994; Lin and Grosschedl 1995) . Gain-of-function and genetic bypass experiments, in which Ebf1 was ectopically expressed in hematopoietic progenitor cells from wild-type mice or mutant mice lacking transcription factors Ikaros or Pu.1, showed that Ebf1 is involved in specifying the B-cell lineage (Zhang et al. 2003; Medina et al. 2004; Pongubala et al. 2008; Reynaud et al. 2008; Zandi et al. 2008 ). In addition, Ebf1 was found to repress alternative cell fate determinants Thal et al. 2009; Lukin et al. 2011) . Early B lymphopoiesis also depends on the functions of Myb (c-Myb) and Miz1, which appear to act upstream of Ebf1 and regulate survival and differentiation of pro-B cells (Fahl et al. 2009; Greig et al. 2010) . Myb has been shown to regulate the expression of the a chain of the IL-7 receptor and cell survival via an IL-7R-independent pathway (Fahl et al. 2009; Greig et al. 2010) . Transcription factors of the Foxo family also regulate the expression of IL-7R, whereby they act in an autoregulatory loop in which IL-7R signaling results in PI3K-dependent phosphorylation and inactivation of Foxo1 and cell cycle progression (Dengler et al. 2008; Kerdiles et al. 2009 ). Foxo1 has been identified as a direct target of both Ebf1 and E2A and might act downstream from these lineage determinants (Zandi et al. 2008; Lin et al. 2010; Treiber et al. 2010) .
Many of the transcription factors that regulate early steps in B lymphopoiesis are also required for peripheral B-cell functions. In particular, Myb has been shown to regulate survival of splenic B cells and the expression of the BAFF-R (Thomas et al. 2005) . The survival of splenic B cells is also regulated by the PI3K arm of the BCR pathway, which results in the inactivation of Foxo transcription factors (Dengler et al. 2008; Srinivasan et al. 2009 ). The proliferative response of splenic B cells to lipopolysaccharide (LPS) involves the function of Pax5, which also represses alternative lineage markers in mature B cells (Wakatsuki et al. 1994; Horcher et al. 2001 ). E2A has a relatively minor role in the generation and survival of splenic B cells (Kwon et al. 2008) . However, E2A is required for the formation of GC B cells, and the E47 isoform of E2A regulates BCR editing upon exposure to self-antigen (Kwon et al. 2008; Beck et al. 2009 ). Moreover, class switch recombination in GC B cells depends on the regulation of activation-induced deaminase (Aid) by Foxo1 and IRF4, the activation of I promoters located upstream of the IgH constant region gene segments, and the function of enhancers in the locus control region (LCR) at the 39 end of the IgH locus (Wolniak et al. 2004; Klein and Dalla-Favera 2008; Stavnezer et al. 2008) . Despite the extensive analysis of the role of Ebf1 in the specification of the B-cell lineage, the early developmental block in Ebf1-null mice has obscured its functions at later stages of B lymphopoiesis.
Results

Ebf1 regulates early B lymphopoiesis in a network of multiple transcription factors
To inactivate Ebf1 conditionally at various stages of B-cell differentiation, we generated mice carrying a targeted allele of Ebf1 in which exons #2 and #3, encoding part of the DNA-binding domain, were flanked by loxP sites (Supplemental Fig. S1A ). The Neo cassette of the targeting construct, flanked by Frt sites, was permanently deleted by crossing Ebf1 +/fl,Neo mice with Act-FLPe mice that express the Flp recombinase (Rodriguez et al. 2000) . Successful targeting of the Ebf1 locus was determined by DNA blot and PCR analysis (Supplemental Fig. S1B,C) . To confirm the loss of Ebf1 function upon deletion by Cre-mediated recombination of the loxP sites, we crossed
Ebf1
fl/fl mice with the mb1 Cre strain, which expresses Cre recombinase in early pro-B cells (Hobeika et al. 2006) . Analysis of the bone marrow of Ebf1 fl/fl mb1
Cre mice by flow cytometry revealed a block of B-cell differentiation at the pre-pro-B-cell stage, which is identical to that observed in Ebf1 D/D -null mice (Supplemental Fig. S1D ; Lin and Grosschedl 1995) . This early developmental block in Ebf1 fl/fl mb1 Cre mice was not rescued by the expression of a TgBcl2 transgene (Supplemental Fig. S1D) .
To examine the function of Ebf1 at various stages of B-cell differentiation, we crossed Ebf1 +/fl mice with RERT Cre mice in which Ebf1 can be deleted in a tamoxifeninducible manner (Guerra et al. 2003 (Fig. 1C) . Consistent with a block in the differentiation of pre-B cells, we also detected fewer Igk germline transcripts (GLTs) in Ebf1-deficient cell cultures (Fig. 1D) .
Differentiation of pre-B cells is dependent on transcription factors Foxo1, Irf4, and Irf8, whereby Foxo1 regulates IL-7Ra expression in pro-B cells and Igk rearrangement in pre-B cells (Amin and Schlissel 2008; Dengler et al. 2008; Herzog et al. 2008 ). Irf4 and Irf8 inhibit cell proliferation and promote k rearrangement by binding to the k 39 enhancer (Lu et al. 2003; Lazorchak et al. 2006; Johnson et al. 2008 ). Ebf1-deficient pro-B cells showed impaired expression of Foxo1 and additional Ebf1-bound transcription factor genes, including Irf4, Irf8, Tcf3 (E2a), Pax5, Aiolos (Ikzf3), Ikaros (Ikzf1), Myb, and Mybl2 ( Fig.  1E ; Supplemental Fig. S1H ; Lin et al. 2010; Treiber et al. 2010) . We also observed reduced expression of IL-7Ra and Bcl2l1. We confirmed direct binding of Ebf1 to Irf4, Irf8, Myb, Mybl2, and Bcl2l1 sequences by chromatin immunoprecipitation (ChIP) analysis (Fig. 1F) . Moreover, previous ChIP-seq analysis of pro-B cells indicated that Ebf1 peak regions in the Irf4 and Irf8 loci overlapped with regions of H3K4me2 chromatin modification ( Fig. 1G ; Lin et al. 2010; Treiber et al. 2010) . No Ebf1 binding was detected at the IL-7Ra and Igk loci (data not shown), suggesting that the decreased IL-7Ra and k germline transcription in Ebf1-deficient pro-B cells is likely due to the impaired expression of Foxo1 and Irf4/8, respectively. Thus, Ebf1 regulates early B-cell differentiation not only in combination with E2A and Pax5, but in an extended network that includes Foxo and Irf transcription factors.
Ebf1 has been implicated in the repression of alternative lineage determinants. In particular, the Id2 gene has been found to be repressed by Ebf1 Thal et al. 2009 ). Moreover, several genes that are expressed in natural killer (NK) cells are up-regulated in pro-B-cell Ebf1 +/À pro-B cells (Lukin et al. 2011) . Therefore, we examined whether the conditional inactivation of Ebf1 in pro-B cells results in derepression of genes specifically expressed in myeloid cells, T cells, or NK cells. With the exception of Fcer1g, no significant changes in myeloid gene expression were observed (Supplemental Fig. S2A ; data not shown). Among the other genes examined, we only observed deregulation of Embigin and Flt3 (Supplemental Fig. S2A ). These data indicate that the suppression of alternative lineage markers is generally maintained immediately after conditional inactivation of Ebf1. Table S1 ). (G) Sequence tag profiles in pro-B cells and splenic B cells at the Irf4 and Irf8 loci. Regions of Ebf1 occupancy and H3K4me2 and H3K4me3 modifications in both pro-B cells and splenic B cells (this study), as well as DNase I hypersensitivity sites (DHS) in CD19
+ B cells and naive T cells (http://genome.ucsc.edu/ENCODE; Sabo et al. 2006) , are shown. Tag density profiles are visualized using the University of California at Santa Cruz (UCSC) Genome Browser. Vertical yellow bars highlight genomic positions of Ebf1-binding sites that were identified by ChIP-seq analysis in pro-B cells Treiber et al. 2010) and splenic B cells (this study).
Unfortunately, the proliferation defect of Ebf1-deficient pro-B cells obscured an assessment of the maintenance of gene expression after multiple rounds of cell divisions.
Survival and proliferation defects of Ebf1-deficient pro-B cells are rescued by forced Myb expression and A-MuLV transformation, respectively
To examine the effects of Ebf1 inactivation on pro-B-cell survival, we determined the numbers of annexin V-positive and annexin V-negative cells between 2 and 6 d after tamoxifen-induced deletion of Ebf1 in vitro. Consistent with the decrease of IL-7Ra expression in Ebf1-deficient pro-B cells, the frequency of annexin/7-AAD-double-negative cells was markedly reduced (Fig. 2A) . This defect was not overcome by the transgenic expression of Bcl2 or the transformation of mutant cells with A-MuLV, which overcomes the need of IL-7R signaling ( Fig. 2B,C ; Danial et al. 1995; Beck et al. 2009 ). Therefore, the cell death of Ebf1-deficient pro-B cells is not a consequence of only defective IL-7R signaling. To attempt to rescue the survival defect of primary or A-MuLV-transformed Ebf1 fl/fl pro-B cells, we transduced mutant cells with a GFP-expressing control retrovirus or bicistronic retroviruses expressing both GFP and various Ebf1-regulated target genes. Expression of IL-7Ra or a constitutive active form of Stat5 failed to overcome the survival defect of primary and transformed Ebf1 fl/fl pro-B cells (Supplemental Fig. S2B ; data not shown). Myb rescued the survival defect of transformed Ebf1 fl/fl pro-B cells as efficiently as Ebf1, although Myb was not sufficient to allow for survival of primary Ebf1 fl/fl pro-B cells ( Fig. 2D ; Supplemental Fig. S2B ). We also observed a partial rescue of transformed Ebf1 fl/fl pro-B cells with Bcl2l1 ( Fig. 2E ), consistent with its role in B-cell survival (Grillot et al. 1996; Cheng et al. 2003) . Despite its implied role in pro-Bcell survival, the Ebf1 target Foxo1 did not rescue the survival defect of transformed Ebf1 fl/fl pro-B cells (Supplemental Fig. S2C ). Quantitative RT-PCR analysis indicated that forced Myb expression restored the expression of Bcl2l1, Foxo1, and Ikzf1, but did not rescue the impaired expression of IL-7Ra and Igll1 (l5) (Supplemental Fig.  S2D ). Thus, Myb acts downstream from Ebf1 to regulate the survival of pro-B cells and the expression of Bcl2l1, but is not sufficient to overcome the requirement for Ebf1 function in cell cycle progression.
We also determined the effects of Ebf1 deletion on cell proliferation and cell cycle progression by performing flow cytometric analysis of cells labeled with CFSE or PI. Ebf1 fl/fl pro-B cells showed marked proliferation and cell cycle defects ( Fig. 2F,G) . In contrast to the survival defect, the cell cycle defect of primary Ebf1-deficient pro-B cells, which accumulate in the G1 phase, was overcome by transformation with A-MuLV (Fig. 2H) . Thus, Ebf1 regulates proliferation and survival of pro-B cells by distinct mechanisms.
Cell cycle progression is regulated by cyclins, cyclindependent kinases (CDKs), retinoblastoma proteins, and CDK inhibitors. In particular, D-type and E-type cyclins regulate G1-phase progression and G1/S transition, respectively. D-type cyclins integrate extracellular signals to G1-phase progression, and complexes of Cdk4/5 and D-cyclins enhance Rb phosphorylation, resulting in activation of E2F transcription factors. Several of these genes are directly or indirectly regulated by Ebf1 (Supplemental Table S1 ; Lin et al. 2010; Treiber et al. 2010) . By quantitative RT-PCR analysis of primary Ebf1-deficient pro-B cells, we confirmed marked changes in the expression of direct Ebf1 targets implicated in cell cycle progression (Fig. 2I ). These genes include E2f2, E2f8, Cdk2, cyclin D2 (Ccnd2), and cyclin D3 (Ccnd3), as well as Cdc6, an essential regulator of the initiation of DNA replication that is also under the control of E2Fs. In addition, the expression of the prosurvival gene Bcl2l1, but not that of Bcl2a1 and Mcl1, was altered in primary and transformed Ebf1-deficient pro-B cells ( Fig. 1E ; Supplemental Fig. S2D ; data not shown). A-MuLV-mediated transformation targets the expression of both D-type cyclins and E2Fs (Coutts et al. 2000; Parada et al. 2001) . In A-MuLV-transformed Ebf1 fl/fl pro-B cells, E2f8, Ccnd2, and Ccnd3 were expressed at similar levels in Ebf1 fl/fl and Ebf1 +/fl pro-B cells (Fig. 2I ),
suggesting that v-Abl compensates for the function of Ebf1 in the regulation of these genes and allows for cell cycle progression in the absence of Ebf1. In primary Ebf1-deficient pro-B cells, we also detected a decrease in Ccnd3 RNA and protein expression ( Fig. 2I;  Supplemental Fig. S2E ). However, we could not rescue the cell cycle defect by forced expression of Ccnd3 (Supplemental Fig. S2F,G) . Primary Ebf1-deficient pro-B cells also showed impaired expression of Cdk2 and the absence of phosphorylation of Cdc2 (Cdk1) (Fig. 2I,J) . Phosphorylation of Cdc2 and expression of Cdk2 were restored in transformed Ebf1-deficient pro-B cells, whereas the phosphorylation of Rb and the expression of Cdc6 remained low (Fig.  2K,L) . This observation raises the possibility that an origin activation checkpoint is bypassed in transformed Ebf1-deficient pro-B cells, allowing them to proceed into an abortive S phase, followed by apoptosis (Tudzarova et al. 2010 ). 
Cd19
Cre mice, which delete the floxed genes in transitional and mature B cells (Rickert et al. 1997; Kraus et al. 2004) . In tamoxifen-treated Ebf1 fl/fl RERT Cre mice, the frequencies and numbers of CD19 + splenic B cells were similar to those found in Ebf1 +/fl RERT Cre mice (Supplemental Fig. S3A,B 
IgM
+ IgD + ) were found at normal frequencies but showed reduced surface expression of CD21 (Fig. 3A) .
In Ebf1 Fig. 3B; Supplemental Fig. S3E,F) . Thus, the entire CD19/CD21 coreceptor complex is affected by the inactivation of Ebf1. In residual MZ B cells and in FO B cells that express CD21 at a high level, we detected abundant unrecombined Ebf1 fl alleles or expression of Ebf1 (Supplemental Fig. S3E,G minimize the appearance of cells with nondeleted alleles, we found reduced expression of Id3 and Cxcr7, which regulate the generation and maintenance of MZ B cells, respectively ( Fig. 3C ; Quong et al. 2004; Wang et al. 2012) . In Ebf1-deficient MZ B cells, we also observed reduced expression of Baff-R (Tnfrsf13c) and Cr2 (Cd21). ChIP analysis to detect binding of Ebf1 to these gene loci indicated that Baff-R is a direct target of Ebf1 in both pro-B and mature B cells (Fig. 3D) . Fig. 3F; Supplemental Fig.  S4D ). Survival of mature B cells depends on two signaling determinants, BCR and BAFF-R, which monitor the presence of antigen and neighboring cells, respectively (Mecklenbrauker et al. 2004; Beck et al. 2009; Srinivasan et al. 2009 ). Analysis of the surface expression of BAFF-R by flow cytometry revealed a reduction in resting and stimulated Ebf1 fl/fl B cells, whereby the defect was more pronounced in stimulated cells (Fig. 3G) . To further examine the requirement of Ebf1 for BAFF-mediated B-cell survival, we determined the effects of exogenous BAFF ligand in unstimulated in vitro cultures. Addition of BAFF rescued, at least in part, the survival defect of Ebf1 fl/fl splenic B cells in a dose-dependent manner (Fig. 3H) . However, we did not observe an enhanced rescue of the Cold 
Impaired BCR and Akt signaling in Ebf1-deficient B cells
The BCR activates several signaling pathways, whereby the BCR-mediated survival signal is governed by PI3K/ Akt signaling (Srinivasan et al. 2009; Okkenhaug and Fruman 2010; Werner et al. 2010) . Ebf1 regulates multiple components of BCR signaling pathways, including Cd79a (Iga), Cd79b (Igb), and Cd19. In anti-IgM-stimulated Ebf1 fl/fl B cells, tyrosine phosphorylation of a subset of proteins, including proteins migrating at ;75 and ;37 kDa, is impaired (Fig. 4A) . In particular, we observed reduced phosphorylation of CD79a, despite normal CD79a protein expression (Fig. 4B) . Moreover, phosphorylation of CD19, a BCR-proximal process, was reduced in anti-IgMstimulated Ebf1 fl/fl B cells (Fig. 4C) . Consistent with the phosphorylation defects, Ca 2+ mobilization in response to anti-IgM stimulation was also impaired in Ebf1 fl/fl B cells (Fig. 4D) . We also examined the PI3K arm of BCR by analyzing the phosphorylation of Akt/PKB. BCR-stimulated phosphorylation of Akt was markedly reduced (Fig.  4C) , suggesting that Ebf1 regulates both canonical and Akt-mediated BCR signaling. In resting Ebf1-deficient B cells, we did not detect an altered expression of genes that are regulated by tonic Akt signaling (Supplemental Fig.  S4E ; Srinivasan et al. 2009) 
RERT
Cre and Ebf1 fl/fl RERT Cre mice revealed differences in the expression of multiple cell cycle-and signaling-related genes (Supplemental Fig. S5A,B) . Of ;200 genes that showed threefold or higher differences in expression, 80% and 20% were down-regulated and up-regulated in Ebf1 fl/fl cells, respectively. Among the Ebf1-activated genes, we identified several genes related to cell cycle control, such as Mcm10, Bub1, and E2f8, as well as genes regulating BCR/Akt signaling, including Cr2, Dok3, and Hck. However, we detected no significant changes in the expression of known Ebf1 target genes, like Cd79a, Pax5, and Blnk (data not shown).
Many putative Ebf1 target genes differed from the target genes previously identified in our microarray and ChIP-seq analyses of pro-B cells (Treiber et al. 2010 ). To identify Ebf1-bound genes in mature splenic B cells, we performed a ChIP-seq analysis. In total, we identified 7424 significant Ebf1 peaks by comparing Ebf1 and control data sets using the CCAT peak-calling algorithm (Treiber et al. 2010) . Assigning the Ebf1-binding sites to genes within 100 kb of the transcription start sites (TSSs), we found 4825 genes that are putatively bound by Ebf1 in mature B cells (Supplemental Table S2 ). To assess the quality of the ChIPseq data, we performed quantitative ChIP experiments on 46 randomly chosen ChIP-seq peaks and could validate 15 of the peaks, which correspond to a greater than eightfold enrichment of Ebf1 tags (Supplemental Table S3 ). For further analysis, we used the top 25% of the peaks (1528 genes), corresponding to the eightfold enrichment. We also compared the data sets with our previous data sets of Ebf1 binding in pro-B cells. We found that ;30% of genes bound in pro-B cells overlapped with those bound in mature B cells (Fig. 5A, left panel) . Using the top 25% of the pro-Bcell library, this fraction of overlapping sites increased to ;44%. Conversely, ;58% of genes bound in mature B cells overlapped with those bound in pro-B cells when the top 25% of the mature B-cell library were used for comparison (Fig. 5A, right panel) . This analysis also showed that the distribution of Ebf1-binding sites is altered in mature B cells and includes significantly more binding sites in promoter-proximal regions (Fig. 5B) . Bioinformatic analysis of Ebf1-binding regions to detect overrepresented transcription factor-binding sites identified different motifs than those found in pro-B cells. In mature B cells, Sp1 and E2F transcription factor-binding motifs were overrepresented in Ebf1-bound regions (Supplemental Table S4 ).
Previous analysis of Ebf1 binding in pro-B cells revealed a good correlation of Ebf1 binding and H3K4me2 modifications (Treiber et al. 2010) . By ChIP-seq analysis of H3K4me2 and H3K4me3 modifications, we also observed this correlation in mature B cells, although in some genes with Ebf1 binding only in mature B cells, such as Pkib, H3K4me2 modifications can already be detected in pro-B cells (Fig. 5C,D) .
Matching the data of the microarray analysis of resting splenic B cells of Ebf1 fl/fl mice with the ChIP-seq data set indicated that 104 of the Ebf1-occupied genes were downregulated and 50 were up-regulated relative to Ebf1 +/fl B cells ( Fig. 5E ; Supplemental Tables S5, S6 ). We also examined the effects of Ebf1 deletion on gene expression in LPS-stimulated B cells. Microarray analysis indicated that a relatively small subset of LPS-regulated genes is dependent on Ebf1, consistent with our finding that NF-kBmediated gene induction is not impaired in Ebf1 fl/fl B cells ( Fig. 5F ; Supplemental Fig. S6 ; Supplemental Tables S7,  S8 ). Virtually all of the functional Ebf1 targets that were confirmed by quantitative RT-PCR were also identified in the ChIP-seq analysis, suggesting that Ebf1 may directly regulate these genes ( Fig. 5G ; Supplemental Table S2 ).
Impaired GC formation in the absence of Ebf1
Activation of splenic B cells by antigen encounter results in the generation of GC B cells that undergo class switch recombination and somatic hypermutation (Klein and Dalla-Favera 2008) . To assess the role of Ebf1 in GC formation, we treated (Fig.  6A) . We also detected impaired proliferation of Ebf1-deficient GC B cells, as determined by BrDU incorporation in vivo (Supplemental Fig. S7A ). Twelve days after immunization, however, the reduction of the number of GC B cells in Ebf1 fl/fl
RERT
Cre mice was less severe, which could be accounted for by the accumulation of cells with nonrecombined Ebf1 fl/fl alleles (Supplemental Fig. S7B) . A progressive loss of Ebf1-deficient GC B cells was also inferred from the analysis of Ebf1 fl/fl
Cg1
Cre mice. In these mice, Cre recombinase is induced specifically in GC B cells by transcription of the Igg1 constant region gene segment 4 d after immunization with T-cell-dependent (TD) antigens (Casola et al. 2006) . In immunized Ebf1 fl/fl
Cre mice, we detected two to three times fewer GC B cells by flow cytometry, and the frequency of nonrecombined Ebf1 fl/fl alleles increased between 7 and 12 d after immunization, consistent with a requirement for Ebf1 in the maintenance of GC B cells (Supplemental Fig. S7C ).
To gain insight into the defect of Ebf1-deficient GC B cells, we immunized Ebf1 +/fl and Ebf1 fl/fl RERT Cre mice with SRBCs and analyzed the spleen by immunohistochemistry 7 d after immunization. In Ebf1 fl/fl spleens, we detected a significant decrease in the size of PNA-positive GCs and in the staining for IgG-positive cells (Fig. 6B) . However, the staining for IgM was similar in Ebf1 fl/fl and Ebf1 +/fl spleens. Quantitative RT-PCR analysis of genes characteristic of GC B cells revealed down-regulation of Cr2, IgCg1, and Irf4 in Ebf1 fl/fl GC B cells (Fig. 6C) . Cr2, encoding CD21, has been implicated in the maintenance of GCs (Fischer et al. 1998; Srinivasan et al. 2009 ), and Irf4 is a key transcription factor for GC B-cell formation Mice were immunized as described in A; genomic DNA was extracted from sorted GC B cells and subjected to nested PCR amplification with two degenerate V and J segment primer pairs, and the amplified products corresponding to J H 3 were separated and cloned. The number of clones sequenced is shown in the circles in the middle of the pie diagrams; each diagram is representative of two independent experiments, with at least 40 cloned sequences each. (E) Relative titers of immunoglobulin subtypes in sera of Ebf1 +/fl RERT Cre mice (black triangles and blue lines represent individual samples and averages, respectively) and Ebf1 fl/fl RERT Cre mice (open circles and red lines represent individual samples and averages, respectively) at the specified days (d), determined by ELISA. (Klein and Dalla-Favera 2008) . In ChIP-seq and ChIP analyses, we detected binding of Ebf1 to an intronic DNase hypersensitivity site (DHS) of Irf4 in mature B cells but not in pro-B cells (Fig. 1G) . However, no significant alteration in somatic hypermutation was detected in immunized Ebf1 fl/fl
RERT
Cre mice (Fig. 6D) . Finally, we examined the secretion of different classes of antibodies by immunizing tamoxifen-treated mice with either T-cellindependent (TI) antigen (NP-LPS) or TD antigen (NP-CGG). Analysis of secreted antibodies by ELISA indicated that the IgM titers were similar in Ebf1 +/fl and Ebf1 fl/fl mice, whereas the levels of IgG3 and IgG1 were reduced in Ebf1 fl/fl mice by a factor of three and a factor of five, respectively (Fig. 6E) .
Similar numbers of CD138 + CD19 À cells were detected in the spleen of Ebf1 fl/fl and Ebf1 +/fl mice 2 d after immunization, and the expression of genes characteristic of plasma cells was similar in these cells (Supplemental Fig. S7D ,E), suggesting that Ebf1 is dispensable for the differentiation of antibody-secreting cells.
Ebf1 regulates Cg1 and Cg3 germline transcription and binds to the IgH 39 LCR
IgH class switch recombination is dependent on cytokine-induced generation of germline transcription that initiates from intronic promoters that are located upstream of the constant region gene segments (Stavnezer et al. 2008 ). In addition, class switching requires multiple cycles of cell division and the expression of Aid (Rush et al. 2005; Stavnezer et al. 2008) . We examined the generation of GLTs as an early marker for class switch recombination in sorted CD21 lo splenic B cells from Ebf1 fl/fl and Ebf +/fl mice because the proliferation defect of Ebf1-deficient B cells precluded an analysis of class switching in vitro (Rush et al. 2005) . In unstimulated and LPS-stimulated Ebf1 fl/fl cells, the generation of g3 GLTs was markedly impaired (Fig. 7A,B ; data not shown). In Ebf1 fl/fl cells stimulated with LPS and IL-4 to favor switching to IgG1 and IgE, we observed a decrease in g1 GLTs. In contrast, the production of g2B GLTs was more efficient in Ebf1 fl/fl cells than in Ebf1
+/fl cells, suggesting that the response to IL-4 stimulation is not impaired. Stimulation of cells with LPS, in combination with TGFb to augment switching to IgG2b, resulted in enhanced generation of g2B GLT in Ebf1 fl/fl cells (Fig. 7B) . Previous studies determined a pivotal role for the 39 Ea LCR in the regulation of GLT expression and class switching to most isotypes (Dunnick et al. 2005) . Genome-wide ChIP-seq analysis indicated that Ebf1 binds to HS4 and HS7 of the 39 Ea LCR already in pro-B cells (Treiber et al. 2010) . We confirmed binding of Ebf1 to these sequences in both pro-B cells and mature B cells by quantitative ChIP analysis (Fig. 7C) . Regulation of GLT expression also involves changes in the accessibility of chromatin at the I promoters and the LCR (Garrett et al. 2005) . Analysis of the acetylation and methylation status of histones H3 and H4 at the IgH constant region in resting and LPS-plus IL-4-stimulated splenic B cells showed that H3K4me2 and H3Ac modifications are reduced at the g3 promoter and switch region in Ebf1 fl/fl cells (Supplemental Fig. S7F ). Thus, Ebf1 regulates class switching to Igg1 and Igg3 by binding to the 39 LCR and inducing changes in the chromatin structure of the g3 switch region.
Discussion
B lymphopoiesis requires the coordination of general processes, such as cell proliferation and survival, with a complex program of differentiation, including the activation of a B-cell-specific expression program, immunoglobulin gene rearrangement, BCR signaling, class switch recombination, and terminal differentiation into plasma cells. Transcriptional regulation of these events is governed by elaborate networks of transcription factors. Here, we show that Ebf1 acts as a molecular node in multiple regulatory networks that operate at different developmental stages. 
Functions of Ebf1 in early stage B cells
In early stage B cells, Ebf1 exerts functions beyond the previously noted roles in specification and commitment of the lineage (Maier et al. 2004; Medina et al. 2004; Pongubala et al. 2008; Treiber et al. 2010) . In particular, Ebf1 regulates cell proliferation and survival, whereby our data suggest that Ebf1 regulates both processes via different targets and pathways. Transformation of Ebf1-deficient pro-B cells with A-MuLV rescues their proliferation defect, but does not overcome their survival defect. Primary Ebf1-deficient pro-B cells arrest in G1 of the cell cycle and show impaired expression of direct Ebf1 targets, including the E2F2 and E2F8 transcriptional regulators of the cell cycle, cyclin D3 (Ccnd3), and the replication initiation factor Cdc6. With the exception of Cdc6, these Ebf1 target genes are almost normally expressed in A-MuLV-transformed Ebf1 fl/fl pro-B cells. Activated Abl kinase has been found to increase the expression of D-type cyclins and E2F transcription factors (Coutts et al. 2000) . Moreover, cyclin D2-deficient bone marrow cells fail to proliferate in response to infection with BCR/ABL-expressing retroviruses (Jena et al. 2002) . Therefore, A-MuLV-mediated transformation may compensate for the Ebf1 dependence of D cyclins and E2Fs. In B-cell leukemias carrying the BCR-ABL1 chromosomal translocation and in A-MuLV-transformed pro-B cells, cyclin D3 transcription is augmented through the constitutive activation of Stat5 (Mandal et al. 2009; Hoelbl et al. 2010) . Thus, cyclin D3 transcription is under the control of both Ebf1 and Stat5. Cyclin D2 and cyclin D3 are abundantly expressed in early stage B cells, and targeted gene inactivation showed that cyclin D3 is preferentially required for pre-B-cell development (Cooper et al. 2006) . Moreover, the marked down-regulation of cyclin D3 is required for the proliferative expansion of GC B cells (Cato et al. 2011) . However, the marked down-regulation of cyclin D3 in primary Ebf1-deficient pro-B cells alone does not account for their proliferation defect because this defect is not overcome by the forced expression of cyclin D3. Therefore, we favor the view that Ebf1 regulates at least two steps in cell cycle progression: the activation of D cyclins and the function of an origin activation checkpoint.
The role of Ebf1 in pro-B-cell survival could, in principle, involve the regulation of IL-7Ra by Ebf1 because IL7Ra signaling and Stat5 expression regulate pro-B-cell survival and prevent Igk rearrangement (Malin et al. 2010) . However, it is unlikely that Ebf1-mediated survival of pro-B cells is linked to the function of IL-7Ra. First, IL-7Ra is indirectly regulated by Ebf1, and second, forced expression of a constitutive form of Stat5 or A-MuLV-mediated transformation failed to overcome the survival defect of Ebf1-deficient pro-B cells. In contrast, forced expression of Bcl2l1, a direct Ebf1 target, rescued, to a large extent, the survival defect of A-MuLV-transformed Ebf1-deficient pro-B cells. Bcl2l1 has been implicated in early stage B-cell survival (Fang et al. 1996; Malin et al. 2010 ). Mcl1 expression is not altered in Ebf1-deficient pro-B cells (data not shown), and therefore Bcl2l1 may act as an Ebf1-regulated determinant of early B-cell survival. However, the survival defect of A-MuLV-transformed Ebf1-deficient pro-B cells is even more efficiently rescued by the forced expression of c-Myb, which plays a major role in B lymphopoiesis and has been shown to regulate cell survival and IL-7 signaling (Fahl et al. 2009 ). Myb proteins regulate both G1/S transition and the G2/M phase of the cell cycle and act in a complex with E2F and Rb proteins (Litovchick et al. 2007) . Therefore, the overexpression of Myb in transformed Ebf1-deficient pro-B cells may compensate for the impaired expression of E2Fs and phosphorylation of Rb.
Ebf1 has also been implicated in the restriction of alternative cell fates Lukin et al. 2011) . In contrast to gain-of-function experiments or the analysis of a heterozygous germline mutation, we did not observe a major change in the expression of alternative lineage determinants after conditional inactivation of Ebf1. Likewise, the expression of Pax5 and many other prominent Ebf1 targets remained virtually unchanged, suggesting that Ebf1 is required for the establishment but not the maintenance of the B-cell fate. However, we were not able to monitor gene expression during multiple rounds of cell divisions, and therefore it is possible that the expression of Pax5 and alternative lineage determinants would be unstable in the absence of Ebf1 and deregulated with prolonged cell culture.
The question also arises as to mechanisms by which Ebf1 regulates different genes in pro-B cells and mature B cells. Stage-specific expression in pro-B cells may be accomplished by competitive recruitment of Ikaros, which is up-regulated in mature B cells and binds to a sequence that overlaps with the Ebf1-binding site. The pro-B-cell-and pre-B-cell-specific expression of l5 (Igll1) has been shown to involve a replacement of promoter-bound Ebf1 by Ikaros proteins at later stages of differentiation (Thompson et al. 2007) . By ChIP-seq analysis, we could confirm the loss of Ebf1 binding in mature B cells (see Fig. 5C ). Conversely, we found that many B-cell-specific genes are bound by Ebf1 specifically in mature B cells, suggesting that the Ebf1-binding site is not accessible due to competitive binding of a repressor or nonpermissive chromatin structure. We showed previously that Ebf1 binding requires a permissive chromatin context (Treiber et al. 2010) . Therefore, we favor the view that in genes specifically bound by Ebf1 in mature B cells, a permissive chromatin context is generated by the binding and/or function of collaborating transcription factors specifically in B cells.
Functions of Ebf1 in mature and GC B cells
At the mature B-cell stage, Ebf1 is also required for proliferation and survival of stimulated cells. Stimulation of Ebf1 fl/fl B cells with LPS, CpG, or anti-IgM fails to induce proliferation, as determined by dilution of CFSE and incorporation of EDU. As these stimuli act via different signaling pathways, we conclude that the inactivation of Ebf1 results in a proliferation and survival defect, rather than in a defect in cell stimulation. Similar to early stage B cells, the effects of Ebf1 inactivation on the survival of ma-ture B cells is less pronounced than that observed in pro-B cells. Survival of resting B cells is regulated by the BAFF-R and PI3K signaling pathways (Kraus et al. 2004; Mecklenbrauker et al. 2004; Srinivasan et al. 2009 ). In Ebf1-deficient B cells, the surface expression of BAFF-R is diminished, and we observed a modest rescue of the survival defect by the addition of excess BAFF. We also observed a marked defect of Akt phosphorylation in anti-BCR-stimulated Ebf1-deficient B cells. However, Ebf1 may be dispensable for tonic BCR/Akt signaling, as we observed neither changes in the number of resting Ebf1-deficient B cells nor alterations in the expression of genes associated with tonic Akt signaling (Supplemental Fig. S4E ; Srinivasan et al. 2009 ).
Many components of the (pre-)BCR signaling pathway were previously identified in genome-wide ChIP-seq analyses as Ebf1-bound targets Treiber et al. 2010) . Consistent with a role of Ebf1 in BCR signaling, we observed defects in Ca 2+ mobilization and tyrosine phosphorylation of anti-IgM-stimulated Ebf1-deficient B cells. In these cells, we observed reduced phosphorylation of Iga (Cd79a), despite normal protein expression. Moreover, we detected a reduction of tyrosine phosphorylation of Cd19 that exceeded the modest twofold decrease in Cd19 RNA and protein expression. CD19 plays an important role in B-cell activation by regulating the formation of BCR microclusters (Depoil et al. 2008 ). Therefore, it is possible that Ebf1-deficient B cells show a more pronounced defect in canonical BCR signaling in the context of membrane-bound ligands. In anti-IgMstimulated Ebf1-deficient B cells, the expression of the Src family kinase Lyn was normal, but we detected a marked decrease of the expression of the Src family kinase gene Blk. We also examined the expression of Ebf1 targets implicated in the regulation of the PI3K arm of the BCR. Although many components of the Akt signaling pathway, including the catalytic and regulatory subunits of PI3K, Pik3cg, Pik3, Pik3r1, and Pik3r5, as well as the adaptor BCAP, are bound by Ebf1, we only detect a deregulation of Pik3c2b (Supplemental Tables S2, S5A ; Treiber et al. 2010) . Consistent with a BCR-proximal defect of Akt signaling, the decrease in CD19 surface expression and phosphorylation could account for an impaired recruitment of PI3K to the BCR. However, most Ebf1 targets in the BCR pathway are only modestly deregulated in Ebf1-deficient B cells, suggesting that Ebf1 plays an important role in the establishment but not the maintenance of the BCR and Akt signaling pathways.
The reduced phosphorylation of Akt and impaired Ca and Foxo1 fl/fl B cells differ in the proliferative response to stimulation with LPS and the defects in GC B-cell functions (Dengler et al. 2008) . In particular, Foxo1 regulates the expression of Aicda, but does not affect locus accessibility and germline transcription of constant region segments (Dengler et al. 2008 ). In contrast, Ebf1 does not regulate Aicda expression, but is required for the generation of Cg1 and Cg3 GLTs. Thus, Ebf1 and Foxo1, which coregulate many genes in early stage B cells ), appear to have only partially overlapping functions in mature B cells.
In summary, our analysis showed that Ebf1 regulates a diverse set of processes in early and late stages of B-cell differentiation. By regulating important components of transcription factor and signaling networks, Ebf1 may act as a molecular node that helps to coordinate proliferation, survival, and differentiation of B-lineage cells.
Materials and methods
Generation of Ebf1
+/fl mice
The targeting construct was designed to introduce loxP sites flanking exons 2 and 3, which encode part of the DNA-binding domain. The flanks and ''deletable'' fragment of the Ebf1 gene were PCR-cloned with the Expand High-Fidelity PCR system (Roche) using genomic DNA from D3V embryonic stem cells as a template. The targeting vector allowed the FLP recombinase-mediated excision of the neomycin selection cassette (gift of R. Fässler). Chimeras were obtained after injection of the targeted embryonic D3V stem cell clones into blastocysts derived from C57BL/6 mice. The chimeras were crossed with C57BL/6 ACTFLPe mice (Rodriguez et al. 2000) to generate an frt-Neo-null allele, referred to as Ebf1 +/fl mice.
Induced deletion of Ebf1 in vitro and in vivo Ebf1
+/fl and Ebf1 fl/fl RERT Cre fetal liver pro-B cells were cultured as described (Treiber et al. 2010) . For inactivation of Ebf1, the B cells were treated with 2 mM 4-hydroxy-tamoxifen for 24 h, washed, and cultured for an additional 4 d. Three independent cultures of each genotype were analyzed for their survival and gene expression pattern. The oral gavage method of tamoxifencitrate administration was performed as described (Hobeika et al. 2006) . Ebf1
+/fl
RERT
Cre and Ebf1 fl/fl RERT Cre mice received 3 mg of tamoxifen-citrate on four consecutive days and were immunized or sacrificed for analysis on the 10th day after the start of the tamoxifen treatment. RERT Cre mice in triplicates, and total RNA was prepared using the RNeasy minikit (Qiagen) according to the manufacturer's protocol. Labeling, hybridization to the Agilent Technologies Microarray Agilent-014868 4x44K, and standard analysis of gene expression were performed by ImaGenes.
For quantitative RT-PCR analysis, RNA was prepared using Trizol reagent (Invitrogen) according to the manufacturer's instructions. SuperScript II Reverse Transcriptase (Invitrogen) was used to reverse-transcribe 500 ng of RNA. Real-time RT-PCR was performed using Power SYBR Green master mix and a 7500 Fast Real-Time PCR system (Applied Biosystems). All quantitative PCR primer sequences are available on request.
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